Correction to: Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1  ≥ 50%

Source: Cancer Immunology, Immunotherapy - Category: Cancer & Oncology Source Type: research